Pleural cancer in humans is a frequently occuring tumor. Recently, cli
nical trials have suggested that chemotherapy and immunotherapy admini
stered intrapleurally may elicit responses in early-stage diseases. Ho
wever, at radiological and pleural endoscopic evaluation, most of the
patients are found to have a visceral pleural involvement that is gene
rally refractory to therapy and leads to a poor prognosis. The goal of
this study was to construct a nude mouse model of human parietal- and
visceral-pleural cancer that could reflect the clinical picture for t
his disease. The model could then be useful for drug discovery for ple
ural cancer. A well-differentiated human lung adenocarcinoma was used
as intact tissue for implantation. Ten mice underwent parietal-pleural
implantation and ten mice visceral-pleural implantation via a novel t
horacotomy procedure we have developed. Symptoms of tumor growth were
determined from weight loss, respiratory distress, or debilitation. Ac
tual tumor growth and spread were measured at autopsy. The mouse survi
val curves of each group were estimated by the Kaplan-Meier method and
the difference of the median survival times was assessed by the Log-r
ank test. The slopes of mean-mouse weight curves were compared using a
standard two-sample t-test. A 100% take rate was achieved in construc
ting the pleural cancer models. Tumor growth was initially assessed by
symptomatology and survival: the median survival time was, respective
ly, 27.9 days and 31 days for visceral-pleural and parietal-pleural im
planted groups (P < 0.05). The comparison between the slopes of the me
an weight curves of corresponding groups demonstrated that visceral-pl
eural implanted animals lost significantly more weight than the pariet
al-pleural implanted animals (P < .001). Both in the visceral- and par
ietal-pleural implanted groups, post-mortem analysis revealed that tum
or grew in all mice demonstrating local and regional spread mimicking
clinical features. However, mediastinal lymph node metastases were obs
erved only in mice with visceral pleural implantation. Patient-like mo
dels of human parietal-pleural and visceral-pleural cancer were constr
ucted in nude mice using histologically intact human specimens. Tumor
symptoms, growth, and spread as well as survival indicated that the pa
rietal-pleural and visceral-pleural models represent, respectively, ea
rly- and advanced-stage disease. These ''patient-like'' nude mouse mod
els of pleural cancer now allow a rational basis for further studies o
f pleural cancer biology,pathophysiology, and therapeutics. (C) 1994 W
iley-Liss, Inc.